21.03.2018 • News

SNC-Lavalin Wins Nova Ethylene Contract

SNC-Lavalin Wins Nova Ethylene Contract
SNC-Lavalin Wins Nova Ethylene Contract

Canadian engineering and construction group SNC-Lavalin, in consortium with TechnipFMC, has won a contract to supply two gas cracking furnaces to Nova Chemicals.

Kevin Dell, senior vice president, oil & gas Canada at SNC-Lavalin, said the award reinforces its reputation in Canada for delivering gas cracking furnaces, a segment of the market that is seeing growing demand. The value of the lumpsum engineering, procurement and construction (EPC) contract was not disclosed.

Under the agreement, SNC Lavalin will be responsible for modular fabrication, erection, construction and pre-commissioning, while TechnipFMC will have primary responsibility for detailed engineering and procurement.

Prior to this latest award, TechnipFMC provided Nova with the associated process technology under a separate licensing agreement. Both SNC-Lavalin and TechnipFMC have also supported Nova in the project’s front end engineering development (FEED) phase.

The furnaces will be installed as part of Nova’s third phase of a program to convert and expand its cracker in Corunna, Ontario, Canada, which is expected to increase the plant's ethylene capacity by more than 50%.

The project is also linked to the construction of a new and second PE facility, with a capacity of 450,000 t/y, which will use Nova’s proprietary Advanced Sclairtech process. Start-up is targeted for late 2021.

Earlier this year, Nova firmed up plans for a joint venture with Total and Borealis to produce ethylene and PE on the Texas Gulf Coast. The JV involves Total’s existing 400,000 t/y PE facility in Bayport, Texas, the development of a new 1 million t/y light feed cracker in Port Arthur, Texas, and a new 625,000 t/y Borstar technology PE plant in Bayport. Start-up is expected in 2020.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.